Literature DB >> 24432704

Isothiourea-catalyzed asymmetric synthesis of β-lactams and β-amino esters from arylacetic acid derivatives and N-sulfonylaldimines.

Siobhan R Smith1, James Douglas, Hugues Prevet, Peter Shapland, Alexandra M Z Slawin, Andrew D Smith.   

Abstract

The isothiourea HBTM-2.1 (5 mol %) catalyzes the asymmetric formal [2 + 2] cycloaddition of both arylacetic acids (following activation with tosyl chloride) and preformed 2-arylacetic anhydrides with N-sulfonylaldimines, generating stereodefined 2,3-diaryl-β-amino esters (after ring-opening) and 3,4-diaryl-anti-β-lactams, respectively, with high diastereocontrol (up to >95:5 dr) and good to excellent enantiocontrol. Deprotection of the N-tosyl substituent within the β-lactam framework was possible without racemization by treatment with SmI2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24432704     DOI: 10.1021/jo402590m

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  10 in total

1.  Asymmetric Isothiourea-Catalysed Formal [3+2] Cycloadditions of Ammonium Enolates with Oxaziridines.

Authors:  Siobhan R Smith; Charlene Fallan; James E Taylor; Ross McLennan; David S B Daniels; Louis C Morrill; Alexandra M Z Slawin; Andrew D Smith
Journal:  Chemistry       Date:  2015-06-12       Impact factor: 5.236

2.  Stereodivergent organocatalytic intramolecular Michael addition/lactonization for the asymmetric synthesis of substituted dihydrobenzofurans and tetrahydrofurans.

Authors:  Dorine Belmessieri; Alix de la Houpliere; Ewen D D Calder; James E Taylor; Andrew D Smith
Journal:  Chemistry       Date:  2014-07-02       Impact factor: 5.236

3.  Enantioselective cis-β-lactam synthesis by intramolecular C-H functionalization from enoldiazoacetamides and derivative donor-acceptor cyclopropenes.

Authors:  Xinfang Xu; Yongming Deng; David N Yim; Peter Y Zavalij; Michael P Doyle
Journal:  Chem Sci       Date:  2015-04-01       Impact factor: 9.825

4.  Crystal structure of 2-[(3S,4S)-4-(anthracen-9-yl)-1-(4-meth-oxy-phen-yl)-2-oxoazetidin-3-yl]-2-aza-2H-phenalene-1,3-dione unknown solvate.

Authors:  Ísmail Çelik; Mehmet Akkurt; Aliasghar Jarrahpour; Javad Ameri Rad; Ömer Çelik
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-02-13

5.  Enantioselective Synthesis of 3,5,6-Substituted Dihydropyranones and Dihydropyridinones using Isothiourea-Mediated Catalysis.

Authors:  Daniel G Stark; Louis C Morrill; David B Cordes; Alexandra M Z Slawin; Timothy J C O'Riordan; Andrew D Smith
Journal:  Chem Asian J       Date:  2015-11-12

6.  Isothiourea-catalysed enantioselective pyrrolizine synthesis: synthetic and computational studies.

Authors:  Daniel G Stark; Patrick Williamson; Emma R Gayner; Stefania F Musolino; Ryan W F Kerr; James E Taylor; Alexandra M Z Slawin; Timothy J C O'Riordan; Stuart A Macgregor; Andrew D Smith
Journal:  Org Biomol Chem       Date:  2016-08-04       Impact factor: 3.876

7.  Solvent directed chemically divergent synthesis of β-lactams and α-amino acid derivatives with chiral isothiourea.

Authors:  Dong-Sheng Ji; Hui Liang; Kai-Xuan Yang; Zhi-Tao Feng; Yong-Chun Luo; Guo-Qiang Xu; Yucheng Gu; Peng-Fei Xu
Journal:  Chem Sci       Date:  2022-01-18       Impact factor: 9.825

8.  Isothiourea-Catalyzed [2 + 2] Cycloaddition of C(1)-Ammonium Enolates and N-Alkyl Isatins.

Authors:  Yusra Abdelhamid; Kevin Kasten; Joanne Dunne; Will C Hartley; Claire M Young; David B Cordes; Alexandra M Z Slawin; Sean Ng; Andrew D Smith
Journal:  Org Lett       Date:  2022-07-18       Impact factor: 6.072

9.  Enantioselective annulations for dihydroquinolones by in situ generation of azolium enolates.

Authors:  Anna Lee; Ashkaan Younai; Christopher K Price; Javier Izquierdo; Rama K Mishra; Karl A Scheidt
Journal:  J Am Chem Soc       Date:  2014-07-15       Impact factor: 15.419

Review 10.  Frontiers in Halogen and Chalcogen-Bond Donor Organocatalysis.

Authors:  Julia Bamberger; Florian Ostler; Olga García Mancheño
Journal:  ChemCatChem       Date:  2019-08-30       Impact factor: 5.686

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.